Navigation

Heart failure (acute decompensated) - nesiritide [ID384]

Nesiritide for the treatment of heart failure

Status: Suspended
Expected date of issue: TBC
Referral date: October 2000
Process: STA
Topic area:
  • Cardiovascular
  • Therapeutic procedures
 

NICE project team

Executive Lead: Peter Littlejohns
Technical Lead: TBC
Communications manager: Phil Ranson
Project manager: Emily Marschke
Assessment Group / Evidence Review Group: Peninsula Technology Assessment Group, University of Exeter
Top


 

Provisional schedule

Closing date for invited submissions / evidence submission: TBC
1st appraisal committee meeting: TBC
2nd appraisal committee meeting TBC
Top


 

Consultees and commentators

To be confirmed

Top


 

Project history

Date Update
10 February 2004 Date of Information Meeting for Consultees added.
14 January 2005 Technology Appraisal Project Manager changed.
17 March 2005 Schedule updated.
6 April 2005 Date of information meeting for Consultees amended.
27 May 2005 Provisional schedule updated.
25 August 2006 This topic was transferred to the Single technology appraisal (STA) process as part of the Institute's 12th wave work programme.
Top


 

Key documents

This page was last updated: 28 February 2012

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.

Selected, reliable information for health and social care in one place

Accessibility | Cymraeg | Freedom of information | Vision Impaired | Contact Us | Glossary | Data protection | Copyright | Disclaimer | Terms and conditions

Copyright 2014 National Institute for Health and Care Excellence. All rights reserved.